Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 53, Issue 2, Pages 300-307Publisher
WILEY
DOI: 10.1002/mnfr.200700514
Keywords
Flavonoid; Gluconeogenesis; Hepatic glucose production; Metformin; Naringenin
Categories
Funding
- The Edith M. Slabaugh Scholarship Fund
- Vivian Endowment Fund
- Fix/Abbott Research Award
Ask authors/readers for more resources
Hepati gluconeogenesis is the major source of fasting hyperglycemia. Here, we investigated the role of the citrus fruit flavonoid naringenin, in the attenuation of hepatic glucose production from hepatoma (Fao) cells. We show that naringenin, but not its glucoside naringin, suppresses hepatic glucose production. Furthermore, unlike insulin-mediated suppression of hepatic glucose production, incubation of hepatocytes with the phosphatidylinositol 3-kinase (PI3-kinase) inhibitor Ly294002 had no effect on the ability of naringenin to suppress hepatic glucose production. Further, naringenin did not increase phosphorylation of Akt at Ser473 or, Thr308, indicating this down-stream target of PI3-kinase is also not a player in naringenin-mediated suppression of hepatic glucose production. Importantly, like the dimethylbiguanide, metformin, naringenin significantly decreased cellular ATP levels without increasing cell cytotoxicity. Together, these results suggest that the aglycone, naringenin, has a role in the attenuation of hyperglycemia and may exert this effect in a manner similar to the drug, metformin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available